Author Response: Effect of Levetiracetam Use Duration on Overall Survival of Isocitrate Dehydrogenase Wild-Type Glioblastoma in Adults: An Observational Study

被引：1
|
作者：
Pallud, Johan
Huberfeld, Gilles
机构：
来源：
NEUROLOGY | 2022年 / 98卷 / 23期
关键词：
D O I：
10.1212/WNL.0000000000200768
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：993 / 993
页数：1
相关论文
共 50 条
  • [41] Grade 2, 3 and Dedifferentiated Chondrosarcomas: A Comparative Study of Isocitrate Dehydrogenase-Mutant and Wild-Type Tumors with Implications for Prognosis and Therapy
    Schoedel, Karen
    Heim, Tanya
    Duensing, Anette
    Lohse, Ines
    Presutti, Laura
    Belayneh, Rebekah
    Bhogal, Sumail
    Singh-Varma, Anya
    Chang, Alexander
    Chandran, Uma
    Marker, Daniel
    Szabo-Rogers, Heather
    Weiss, Kurt
    CANCERS, 2024, 16 (02)
  • [42] Association of preoperative seizures with reduced expression of soluble CD163, an M2 macrophage marker, in the cerebrospinal fluid in isocitrate dehydrogenase wild-type glioblastoma
    Yamanishi, Shunsuke
    Nagashima, Hiroaki
    Tanaka, Kazuhiro
    Uno, Takiko
    Ikeuchi, Yusuke
    Iwahashi, Hirofumi
    Hashiguchi, Mitsuru
    Horii, Shintaro
    Itoh, Tomoo
    Muragaki, Yoshihiro
    Sasayama, Takashi
    JOURNAL OF NEURO-ONCOLOGY, 2025, 171 (01) : 95 - 103
  • [43] Prediction of Core Signaling Pathway by Using Diffusion-and Perfusion-based MRI Radiomics and Next-generation Sequencing in Isocitrate Dehydrogenase Wild-type Glioblastoma
    Park, Ji Eun
    Kim, Ho Sung
    Park, Seo Young
    Nam, Soo Jung
    Chun, Sung-Min
    Jo, Youngheun
    Kim, Jeong Hoon
    RADIOLOGY, 2020, 294 (02) : 388 - 397
  • [44] Dabrafenib Plus Trametinib: An Impressive Response in an Adult Patient With BRAF V600E- Mutated and Isocitrate Dehydrogenase (IDH) Wild-Type Glioma
    Costa, Ines N.
    Reis, Joana
    Pinheiro, Jorge
    Silva, Roberto
    Fernandes, Catarina
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [45] TARGETED NEXT GENERATION SEQUENCING (NGS) OF YOUNG ADULTS WITH ISOCITRATE-DEHYDROGENASE WILD-TYPE GLIOBLASTOMA (IDH-WT GBM) REVEALS NEGATIVE PROGNOSTIC IMPACT OF EPIDERMAL GROWTH FACTOR RECEPTOR AMPLIFICATION (EGFRAMP)
    Hoffman, Daniel
    Abdullah, Kalil
    Binder, Zev
    O'Rourke, Donald
    Desai, Arati
    Morrissette, Jennifer
    Brem, Steven
    Bagley, Stephen
    NEURO-ONCOLOGY, 2018, 20 : 167 - 167
  • [46] Exploratory pooled analysis evaluating the effect of sequence of biological therapies on overall survival in patients with RAS wild-type metastatic colorectal carcinoma
    Peeters, Marc
    Forget, Frederic
    Karthaus, Meinolf
    Valladares-Ayerbes, Manuel
    Zaniboni, Alberto
    Demonty, Gaston
    Guan, Xuesong
    Rivera, Fernando
    ESMO OPEN, 2018, 3 (02)
  • [47] Investigational cyclin-dependent kinase 4/6 inhibitor GLR2007 demonstrates activity against isocitrate dehydrogenase wild-type glioblastoma and other solid tumors in mice xenograft models
    Yin, Lei
    Yao, Zhenglin
    Wang, Yue
    Mazuranic, Michelle
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] Supramaximal versus gross total resection in Glioblastoma, IDH wild-type and Astrocytoma, IDH-mutant, grade 4, effect on overall and progression free survival: systematic review and meta-analysis
    Mier-Garcia, Juan F. F.
    Ospina-Santa, Stefania
    Orozco-Mera, Javier
    Ma, Ruichong
    Plaha, Puneet
    JOURNAL OF NEURO-ONCOLOGY, 2023, 164 (1) : 31 - 41
  • [49] Supramaximal versus gross total resection in Glioblastoma, IDH wild-type and Astrocytoma, IDH-mutant, grade 4, effect on overall and progression free survival: systematic review and meta-analysis
    Juan F. Mier-García
    Stefanía Ospina-Santa
    Javier Orozco-Mera
    Ruichong Ma
    Puneet Plaha
    Journal of Neuro-Oncology, 2023, 164 : 31 - 41
  • [50] The impact of interaction between verteporfin and yes-associated protein 1/transcriptional coactivator with PDZ-binding motif-TEA domain pathway on the progression of isocitrate dehydrogenase wild-type glioblastoma
    Osama, Mahmoud
    Essibayi, Muhammed Amir
    Osama, Mona
    Ibrahim, Ismail A.
    Mostafa, Mostafa Nasr
    Eksi, Murat Sakir
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2023, 15
12345